IP Verse

Modulators Of Pharmacokinetic Properties Of Therapeutics

PatentPatent Analysis

EP3150586

GILEAD SCIENCES
Application Number
EP16180589A
Filing Date
Feb 22, 2008
Status
Granted And Under Opposition
Dec 6, 2019
Grant Date
Jan 8, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3595667B1
EP2655623B2
EP4070788B1

Bibliography

The patent EP3150586B1 was granted to Gilead Sciences on Jan 8, 2020 following the initial filing on Feb 22, 2008 under the application number EP16180589A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

COOKEOct 8, 2020ADMISSIBLE
TEVA PHARMACEUTICALSOct 6, 2020ADMISSIBLE
STADA ARZNEIMITTELJan 10, 2020ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents